Oka JI - Search Results

1

Intranasal administration of neuromedin U derivatives containing cell-penetrating peptides and a penetration-accelerating sequence induced memory improvements in mice.

Sasaki-Hamada S, Funane T, Nakao Y, Sasaki R, Nagai M, Ueta Y, Yoshizawa K, Horiguchi M, Yamashita C, Oka JI. Sasaki-Hamada S, et al. Among authors: oka ji. Peptides. 2018 Jan;99:241-246. doi: 10.1016/j.peptides.2017.10.010. Epub 2017 Oct 25. Peptides. 2018. PMID: 29079533

2

Neuromedin U inhibits inflammation-mediated memory impairment and neuronal cell-death in rodents.

Iwai T, Iinuma Y, Kodani R, Oka J. Iwai T, et al. Neurosci Res. 2008 May;61(1):113-9. doi: 10.1016/j.neures.2008.01.018. Epub 2008 Feb 8. Neurosci Res. 2008. PMID: 18336945

3

Riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines.

Sugiyama A, Saitoh A, Iwai T, Takahashi K, Yamada M, Sasaki-Hamada S, Oka J, Inagaki M, Yamada M. Sugiyama A, et al. Neuropharmacology. 2012 Jun;62(8):2489-98. doi: 10.1016/j.neuropharm.2012.02.012. Epub 2012 Feb 21. Neuropharmacology. 2012. PMID: 22377384

4

Exendin (5-39), an antagonist of GLP-1 receptor, modulates synaptic transmission via glutamate uptake in the dentate gyrus.

Kobayashi K, Iwai T, Sasaki-Hamada S, Kamanaka G, Oka J. Kobayashi K, et al. Brain Res. 2013 Apr 10;1505:1-10. doi: 10.1016/j.brainres.2013.01.012. Epub 2013 Jan 11. Brain Res. 2013. PMID: 23318256

5

Glucagon-like peptide-2 but not imipramine exhibits antidepressant-like effects in ACTH-treated mice.

Iwai T, Ohnuki T, Sasaki-Hamada S, Saitoh A, Sugiyama A, Oka J. Iwai T, et al. Behav Brain Res. 2013 Apr 15;243:153-7. doi: 10.1016/j.bbr.2013.01.010. Epub 2013 Jan 16. Behav Brain Res. 2013. PMID: 23333402

6

Riluzole does not affect hippocampal synaptic plasticity and spatial memory, which are impaired by diazepam in rats.

Sasaki-Hamada S, Sacai H, Sugiyama A, Iijima T, Saitoh A, Inagaki M, Yamada M, Oka J. Sasaki-Hamada S, et al. J Pharmacol Sci. 2013;122(3):232-6. doi: 10.1254/jphs.13052sc. Epub 2013 Jul 2. J Pharmacol Sci. 2013. PMID: 23823932 Free article.

7

Characterization of the hypotensive effects of glucagon-like peptide-2 in anesthetized rats.

Iwai T, Kaneko M, Sasaki-Hamada S, Oka J. Iwai T, et al. Neurosci Lett. 2013 Aug 29;550:104-8. doi: 10.1016/j.neulet.2013.07.004. Epub 2013 Jul 15. Neurosci Lett. 2013. PMID: 23867714

8

Kampo formulations, chotosan, and yokukansan, for dementia therapy: existing clinical and preclinical evidence.

Matsumoto K, Zhao Q, Niu Y, Fujiwara H, Tanaka K, Sasaki-Hamada S, Oka J. Matsumoto K, et al. J Pharmacol Sci. 2013;122(4):257-69. doi: 10.1254/jphs.13r03cr. Epub 2013 Jul 25. J Pharmacol Sci. 2013. PMID: 23883485 Free article. Review.

9

Neuronal Fos-like immunoreactivity associated with dexamethasone-induced hypertension in rats and effects of glucagon-like peptide-2.

Sasaki-Hamada S, Ito K, Oka J. Sasaki-Hamada S, et al. Life Sci. 2013 Nov 26;93(23):889-96. Life Sci. 2013. PMID: 24383084

10

Glucagon-like peptide-1 protects synaptic and learning functions from neuroinflammation in rodents.

Iwai T, Sawabe T, Tanimitsu K, Suzuki M, Sasaki-Hamada S, Oka J. Iwai T, et al. J Neurosci Res. 2014 Apr;92(4):446-54. doi: 10.1002/jnr.23335. Epub 2014 Jan 27. J Neurosci Res. 2014. PMID: 24464856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters